UBS O'Connor’s KalVista Pharmaceuticals KALV Stock Holding History

UBS O'Connor’s Portfolio KALV Stock Details KALV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$898K	Sell
2025 Q1	$1.96M	Sell
2024 Q4	$1.46M	Buy
2024 Q3	$1.57M	Buy
2024 Q2	$1.45M	Buy
2024 Q1	$973K	Buy